The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

DIRECTOR DEALINGS: Burford Capital Deputy Chair Buys Shares

Wed, 14th Aug 2019 17:58

(Alliance News) - Burford Capital Ltd said Deputy Chair High Wilson purchased around GBP206,800 in stock in a deal on Tuesday.

Wilson bought 29,410 shares at a price of 703 pence per share, following which he now holds 254,410 shares in total, reflecting a 0.1% stake.

Last week, on Wednesday, US research firm Muddy Waters LLC attacked Burford, accusing it of being a "poor business masquerading as a great one". It alleged Burford is manipulating metrics and "greatly" misleading investors.

Burford's shares have plunged since the report, with the stock closing at 777.00 in London on Wednesday, down 6.6%. Last Wednesday, they opened at 1,130.00p, a drop of 31% in a week.

Since then, the two have exchanged a tit-for-tat spat over the allegations. On Monday, Burford said it has contacted regulators and prosecutors after saying it had found "material" illegal market manipulation and trading of its shares around the time of the release on the original report.

On Tuesday, Muddy Waters said: "Leave it to former trial lawyers to talk so much, and yet say so little. Burford's written response and numbing two-hour call did nothing to dispel our view Burford aggressively marks its cases up to generate non-cash profits, manipulates its non-IFRS return on capital invested and internal rate of return metrics in order to justify its fair value gains, deliberately confuses investors about the extent of its fair value gains in each period, and has a fragile balance sheet with too much leverage, particularly given the excessive costs the business runs (of which a significant portion could be management compensation)."

Related Shares

More News
18 Mar 2024 19:06

EARNINGS AND TRADING: JPMorgan US Smaller optimistic; Burford buyback

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...

14 Mar 2024 14:16

Burford Capital annual profit surges on capital provision boost

(Alliance News) - Burford Capital Ltd on Thursday reported a significantly higher return on tangible equity amid an increased profit and revenue, hail...

14 Mar 2024 11:22

Burford Capital reports year of solid growth

(Sharecast News) - Burford Capital reported significant gains and robust growth in its annual results on Thursday, with a record surge in realised gai...

8 Mar 2024 14:29

UK earnings, trading statements calendar - next 7 days

30 Jan 2024 16:52

IN BRIEF: Burford Capital closes USD275.0 million private note offer

Burford Capital Ltd - litigation finance provider with offices in London, New York and elsewhere - Closes private offering of USD275.0 million aggrega...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.